SEC Form 4 research
| Issuer | BRAINSTORM CELL THERAPEUTICS INC. |
|---|---|
| Tickers | BCLI |
| Reporting owners | 43 |
| Officers and directors | 15 |
| Last public filing | 2026-07-29 |
| Available | Trade date | Reporting owners | Code | Shares | Price | Reported value |
|---|---|---|---|---|---|---|
| 2026-07-28 | 2026-07-24 | FRENKEL JACOB A | A | 100,000 | $0 | Not reported |
| 2026-07-28 | 2026-07-24 | Pitts Peter Joe | A | 900,000 | $0 | Not reported |
Public filing evidence only. NexusTrade's simulated follower strategies are hypothetical, modeled results — not live trading returns and not investment advice.